{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:26Z","timestamp":1791214046363,"version":"4.1.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.3892\/mmr.2016.5703","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T08:47:09Z","timestamp":1472806029000},"page":"3785-3790","source":"Crossref","is-referenced-by-count":6,"title":["Bioinformatics analysis of gene expression profiles of dermatomyositis"],"prefix":"10.3892","volume":"14","author":[{"given":"Liang-Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Cui","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng-Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Hua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"key20180108025825_b1-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: Specificity and heterogeneity across diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"key20180108025825_b2-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","article-title":"Incidence of dermatomyositis and clinically amyopathic dermatomyositis: A population-based study in Olmsted County, Minnesota","volume":"146","author":"Bendewald","year":"2010","journal-title":"Arch Dermatol"},{"key":"key20180108025825_b3-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s004150050087","article-title":"Inflammatory myopathies and systemic disorders: A review of immunopathogenetic mechanisms and clinical features","volume":"244","author":"Mantegazza","year":"1997","journal-title":"J Neurol"},{"key":"key20180108025825_b4-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/isbn.978-3-8055-8392-3","article-title":"Dermatomyositis","volume-title":"Dermatologic Immunity Curr Dir Autoimmun","author":"Nickoloff","year":"2008"},{"key":"key20180108025825_b5-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"key20180108025825_b6-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaut.2010.07.006","article-title":"Characterization of regulatory T cells in patients with dermatomyositis","volume":"35","author":"Antiga","year":"2010","journal-title":"J Autoimmun"},{"key":"key20180108025825_b7-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0889-857X(02)00029-7","article-title":"Genetic and environmental risk factors for idiopathic inflammatory myopathies","volume":"28","author":"Reed","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"key20180108025825_b8-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/01.bor.0000434676.70268.66","article-title":"Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies","volume":"25","author":"Rothwell","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"key20180108025825_b9-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-857X(02)00030-3","article-title":"Muscle biopsy findings in inflammatory myopathies","volume":"28","author":"Dalakas","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"key20180108025825_b10-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40265-014-0240-6","article-title":"Innate immune-response mechanisms in dermatomyositis: An update on pathogenesis, diagnosis and treatment","volume":"74","author":"Hornung","year":"2014","journal-title":"Drugs"},{"key":"key20180108025825_b11-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.4355","article-title":"Sustained autoimmune mechanisms in dermatomyositis","volume":"233","author":"Greenberg","year":"2014","journal-title":"J Pathol"},{"key":"key20180108025825_b12-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/path.4346","article-title":"Altered RIG-I\/DDX58-mediated innate immunity in dermatomyositis","volume":"233","author":"Su\u00e1rez-Calvet","year":"2014","journal-title":"J Pathol"},{"key":"key20180108025825_b13-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2164-7-252","article-title":"Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma","volume":"7","author":"Diboun","year":"2006","journal-title":"BMC Genomics"},{"key":"key20180108025825_b14-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"key20180108025825_b15-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: A database of predicted functional associations between proteins","volume":"31","author":"von Mering","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"key20180108025825_b16-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"key20180108025825_b17-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"key20180108025825_b18-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis subjects is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med"},{"key":"key20180108025825_b19-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11926-011-0166-x","article-title":"Pathogenesis of dermatomyositis: Role of cytokines and interferon","volume":"13","author":"Kao","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"key20180108025825_b20-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/BOR.0b013e3282efe261","article-title":"A gene expression approach to study perturbed pathways in myositis","volume":"19","author":"Greenberg","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"key20180108025825_b21-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key20180108025825_b22-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","article-title":"Type I interferons: Crucial participants in disease amplification in autoimmunity","volume":"6","author":"Hall","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"key20180108025825_b23-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"key20180108025825_b24-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.immuni.2015.01.012","article-title":"DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity","volume":"42","author":"H\u00e4rtlova","year":"2015","journal-title":"Immunity"},{"key":"key20180108025825_b25-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/14728222.2013.837886","article-title":"Targeting CCL5 in inflammation","volume":"17","author":"Marques","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"key20180108025825_b26-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key20180108025825_b27-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejcb.2011.09.011","article-title":"Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target","volume":"91","author":"Crescioli","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"key20180108025825_b28-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/ar4583","article-title":"Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse","volume":"16","author":"Kim","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"key20180108025825_b29-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/art.33350","article-title":"Immature muscle precursors are a source of interferon-\u03b2 in myositis: Role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation","volume":"64","author":"Tournadre","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key20180108025825_b30-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e31821f440a","article-title":"Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies","volume":"76","author":"Cappelletti","year":"2011","journal-title":"Neurology"},{"key":"key20180108025825_b31-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2015.06.009","article-title":"Role of Toll-like receptors and retinoic acid inducible gene I in endogenous production of type I interferon in dermatomyositis","volume":"285","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"key20180108025825_b32-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key20180108025825_b33-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2015.02.007","article-title":"Discovery of new biomarkers of idiopathic inflammatory myopathy","volume":"444","author":"Lu","year":"2015","journal-title":"Clin Chim Acta"},{"key":"key20180108025825_b34-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"e61505","DOI":"10.1371\/journal.pone.0061505","article-title":"When is hub gene selection better than standard meta-analysis?","volume":"8","author":"Langfelder","year":"2013","journal-title":"PloS One"},{"key":"key20180108025825_b35-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1073\/pnas.93.1.211","article-title":"Immunoregulatory properties of ISG15, an interferon-induced cytokine","volume":"93","author":"D'Cunha","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108025825_b36-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.0504754102","article-title":"Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108025825_b37-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cyto.2014.11.026","article-title":"The role of type I interferons and other cytokines in dermatomyositis","volume":"73","author":"Arshanapalli","year":"2015","journal-title":"Cytokine"},{"key":"key20180108025825_b38-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clim.2006.05.011","article-title":"MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: Association with muscle involvement","volume":"120","author":"O'Connor","year":"2006","journal-title":"Clin Immunol"},{"key":"key20180108025825_b39-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jclinpath-2011-200138","article-title":"Validity of internal expression of the major histocompatibility complex class I in the diagnosis of inflammatory myopathies","volume":"65","author":"Salaroli","year":"2012","journal-title":"J Clin Pathol"},{"key":"key20180108025825_b40-mmr-14-04-3785","first-page":"136","article-title":"Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies","volume":"75","author":"van der Pas","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20180108025825_b41-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1038\/emm.2014.110","article-title":"Oligoadenylate synthase-like (OASL) proteins: Dual functions and associations with diseases","volume":"47","author":"Choi","year":"2015","journal-title":"Exp Mol Med"},{"key":"key20180108025825_b42-mmr-14-04-3785","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/art.38400","article-title":"Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: Biomarkers identified by analysis of gene expressionin peripheral blood mononuclear cells using genome-wide DNA microarray","volume":"66","author":"Sanayama","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.5703\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T05:16:40Z","timestamp":1515388600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.5703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,9,2]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.3892\/mmr.2016.5703"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.5703","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]}}}